The short answer is: Yes, its a safe and common practice
There is strong evidence from randomised cardiovascular outcome trials (CVOTs) that several long-acting GLP-1 RAs (liraglutide, dulaglutide and subcutaneous semaglutide) provide cardiovascular protection to individuals with T2D with pre-existing cardiovascular disease (secondary prevention) or at high risk of CV events, and to a lesser extent those without overt atherosclerotic vascular disease (primary prevention
You're missing the transport mechanism
Acne is an inflammatory skin condition
Yes, the FDA says the drug shortage for semaglutide is over
GLP-1 Support is science-backed and designed to help women feel steadier, calmer, and more in control every day. Luna Aziz, CEO & Founder, Legendairy Milk Please Note: Legendairy Milk GLP-1 Support is intended for women after breastfeeding